PGII Rapid Quantitative Test

Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).

PGI Rapid Quantitative Test

PGI/PGII Rapid Quantitative Test

Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any signiﬁcant rise in serum creatinine.

TESTO Rapid Quantitative Test (Chemiluminescence Immunoassay)

TESTO Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Testosterone (TESTO) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free thyroxine 4 (FT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.

FSH Rapid Quantitative Test (Chemiluminescence Immunoassay)

FSH Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Follicle-stimulating hormone (FSH) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

Specimen Types	Serum
Specimen Capacity	10μL
Reaction Time	15 min
Sample Capacity	80μL
PGII Detection Range	0.5-200.0ng/mL

Fluorescence Immunoassay

Gastrointestinal Marker

PGII Rapid Quantitative Test